nodes	percent_of_prediction	percent_of_DWPC	metapath
Sucralfate—PGA5—renal system—muscle cancer	0.0311	0.086	CbGeAlD
Sucralfate—FGB—embryo—muscle cancer	0.0279	0.0773	CbGeAlD
Sucralfate—FGA—Podofilox—Etoposide—muscle cancer	0.0248	1	CbGdCrCtD
Sucralfate—FGA—embryo—muscle cancer	0.0239	0.0661	CbGeAlD
Sucralfate—FGB—renal system—muscle cancer	0.0211	0.0585	CbGeAlD
Sucralfate—PGA5—head—muscle cancer	0.0208	0.0576	CbGeAlD
Sucralfate—FGA—renal system—muscle cancer	0.0181	0.0501	CbGeAlD
Sucralfate—FGG—testis—muscle cancer	0.0177	0.049	CbGeAlD
Sucralfate—EGF—embryo—muscle cancer	0.0174	0.0483	CbGeAlD
Sucralfate—FGB—bone marrow—muscle cancer	0.016	0.0442	CbGeAlD
Sucralfate—EGF—smooth muscle tissue—muscle cancer	0.0137	0.038	CbGeAlD
Sucralfate—FGA—bone marrow—muscle cancer	0.0137	0.0378	CbGeAlD
Sucralfate—FGB—testis—muscle cancer	0.0136	0.0378	CbGeAlD
Sucralfate—EGF—renal system—muscle cancer	0.0132	0.0366	CbGeAlD
Sucralfate—FGF2—smooth muscle tissue—muscle cancer	0.0121	0.0335	CbGeAlD
Sucralfate—FGA—head—muscle cancer	0.0121	0.0335	CbGeAlD
Sucralfate—EGF—cardiac atrium—muscle cancer	0.0118	0.0327	CbGeAlD
Sucralfate—FGA—testis—muscle cancer	0.0117	0.0323	CbGeAlD
Sucralfate—EGF—tendon—muscle cancer	0.0103	0.0285	CbGeAlD
Sucralfate—EGF—vagina—muscle cancer	0.00956	0.0265	CbGeAlD
Sucralfate—FGF2—tendon—muscle cancer	0.00909	0.0252	CbGeAlD
Sucralfate—EGF—head—muscle cancer	0.00883	0.0245	CbGeAlD
Sucralfate—EGF—testis—muscle cancer	0.00853	0.0236	CbGeAlD
Sucralfate—FGF2—vagina—muscle cancer	0.00843	0.0234	CbGeAlD
Sucralfate—FGF2—testis—muscle cancer	0.00752	0.0208	CbGeAlD
Sucralfate—ALB—testis—muscle cancer	0.00295	0.00817	CbGeAlD
Sucralfate—FGF2—DAP12 interactions—FOXO4—muscle cancer	0.00143	0.00233	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—FOXO4—muscle cancer	0.00143	0.00233	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—FOXO4—muscle cancer	0.00143	0.00233	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—FOXO4—muscle cancer	0.00142	0.00231	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—FOXO4—muscle cancer	0.0014	0.00229	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—FOXO4—muscle cancer	0.0014	0.00228	CbGpPWpGaD
Sucralfate—EGF—Downstream signal transduction—KIT—muscle cancer	0.00137	0.00223	CbGpPWpGaD
Sucralfate—EGF—Response to elevated platelet cytosolic Ca2+—VEGFA—muscle cancer	0.00137	0.00223	CbGpPWpGaD
Sucralfate—FGF2—Differentiation Pathway—VEGFA—muscle cancer	0.00137	0.00223	CbGpPWpGaD
Sucralfate—EGF—Signaling by FGFR—KIT—muscle cancer	0.00137	0.00222	CbGpPWpGaD
Sucralfate—EGF—Signaling by ERBB2—KIT—muscle cancer	0.00136	0.00221	CbGpPWpGaD
Sucralfate—EGF—DAP12 signaling—KIT—muscle cancer	0.00135	0.0022	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	0.00135	0.00219	CbGpPWpGaD
Sucralfate—EGF—Downstream signaling events of B Cell Receptor (BCR)—KIT—muscle cancer	0.00133	0.00217	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—FOXO4—muscle cancer	0.00132	0.00215	CbGpPWpGaD
Sucralfate—FGF2—PI-3K cascade—KIT—muscle cancer	0.00129	0.0021	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—IGF2—muscle cancer	0.00128	0.00208	CbGpPWpGaD
Sucralfate—EGF—DAP12 interactions—KIT—muscle cancer	0.00127	0.00207	CbGpPWpGaD
Sucralfate—EGF—Fc epsilon receptor (FCERI) signaling—KIT—muscle cancer	0.00127	0.00207	CbGpPWpGaD
Sucralfate—EGF—Signaling by FGFR in disease—KIT—muscle cancer	0.00127	0.00207	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—FOXO1—muscle cancer	0.00127	0.00206	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—FOXO4—muscle cancer	0.00127	0.00206	CbGpPWpGaD
Sucralfate—FGF2—PI3K/AKT activation—KIT—muscle cancer	0.00126	0.00205	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR—KIT—muscle cancer	0.00126	0.00205	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—IGF2—muscle cancer	0.00125	0.00204	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—IGF2—muscle cancer	0.00125	0.00204	CbGpPWpGaD
Sucralfate—FGF2—GAB1 signalosome—KIT—muscle cancer	0.00125	0.00204	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR in Cancer—KIT—muscle cancer	0.00125	0.00203	CbGpPWpGaD
Sucralfate—EGF—Signaling by PDGF—KIT—muscle cancer	0.00124	0.00202	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—CD34—muscle cancer	0.00124	0.00202	CbGpPWpGaD
Sucralfate—FGF2—Role of LAT2/NTAL/LAB on calcium mobilization—KIT—muscle cancer	0.00122	0.00199	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—FOXO1—muscle cancer	0.00121	0.00197	CbGpPWpGaD
Sucralfate—EGF—Signaling by SCF-KIT—MDM2—muscle cancer	0.0012	0.00196	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—FOXO1—muscle cancer	0.00119	0.00194	CbGpPWpGaD
Sucralfate—EGF—B Cell Activation—KIT—muscle cancer	0.00118	0.00192	CbGpPWpGaD
Sucralfate—EGF—Downstream signaling of activated FGFR—MDM2—muscle cancer	0.00115	0.00187	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—FOXO1—muscle cancer	0.00114	0.00185	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—FOXO1—muscle cancer	0.00114	0.00185	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—FOXO1—muscle cancer	0.00113	0.00185	CbGpPWpGaD
Sucralfate—EGF—Signaling by ERBB4—MDM2—muscle cancer	0.00113	0.00184	CbGpPWpGaD
Sucralfate—FGF2—Constitutive PI3K/AKT Signaling in Cancer—MDM2—muscle cancer	0.00113	0.00184	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—FOXO1—muscle cancer	0.00113	0.00184	CbGpPWpGaD
Sucralfate—EGF—NGF signalling via TRKA from the plasma membrane—KIT—muscle cancer	0.00113	0.00183	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—FOXO1—muscle cancer	0.00112	0.00183	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—FOXO1—muscle cancer	0.00111	0.0018	CbGpPWpGaD
Sucralfate—FGF2—Integrins in angiogenesis—VEGFA—muscle cancer	0.0011	0.00179	CbGpPWpGaD
Sucralfate—FGF2—Endochondral Ossification—VEGFA—muscle cancer	0.00109	0.00177	CbGpPWpGaD
Sucralfate—EGF—Downstream signal transduction—MDM2—muscle cancer	0.00108	0.00176	CbGpPWpGaD
Sucralfate—EGF—Signaling by FGFR—MDM2—muscle cancer	0.00108	0.00175	CbGpPWpGaD
Sucralfate—EGF—Signaling by ERBB2—MDM2—muscle cancer	0.00107	0.00174	CbGpPWpGaD
Sucralfate—EGF—DAP12 signaling—MDM2—muscle cancer	0.00106	0.00173	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—FOXO1—muscle cancer	0.00106	0.00172	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—FOXO1—muscle cancer	0.00106	0.00172	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—FOXO1—muscle cancer	0.00106	0.00172	CbGpPWpGaD
Sucralfate—EGF—Downstream signaling events of B Cell Receptor (BCR)—MDM2—muscle cancer	0.00105	0.00171	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—FOXO1—muscle cancer	0.00105	0.0017	CbGpPWpGaD
Sucralfate—FGB—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.00104	0.0017	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—FOXO1—muscle cancer	0.00104	0.00169	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—FOXO1—muscle cancer	0.00103	0.00168	CbGpPWpGaD
Sucralfate—FGG—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.00102	0.00166	CbGpPWpGaD
Sucralfate—FGA—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.00102	0.00166	CbGpPWpGaD
Sucralfate—FGF2—PI-3K cascade—MDM2—muscle cancer	0.00102	0.00166	CbGpPWpGaD
Sucralfate—EGF—DAP12 interactions—MDM2—muscle cancer	0.001	0.00163	CbGpPWpGaD
Sucralfate—EGF—Signaling by FGFR in disease—MDM2—muscle cancer	0.001	0.00163	CbGpPWpGaD
Sucralfate—EGF—Fc epsilon receptor (FCERI) signaling—MDM2—muscle cancer	0.001	0.00163	CbGpPWpGaD
Sucralfate—FGF2—PI3K/AKT activation—MDM2—muscle cancer	0.000993	0.00162	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR—MDM2—muscle cancer	0.000993	0.00162	CbGpPWpGaD
Sucralfate—FGF2—GAB1 signalosome—MDM2—muscle cancer	0.000985	0.0016	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR in Cancer—MDM2—muscle cancer	0.000984	0.0016	CbGpPWpGaD
Sucralfate—EGF—Signaling by PDGF—MDM2—muscle cancer	0.000979	0.00159	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—FOXO1—muscle cancer	0.000978	0.00159	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—KIDINS220—muscle cancer	0.000977	0.00159	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—FOXO4—muscle cancer	0.000974	0.00159	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—KIT—muscle cancer	0.000965	0.00157	CbGpPWpGaD
Sucralfate—FGF2—Role of LAT2/NTAL/LAB on calcium mobilization—MDM2—muscle cancer	0.000963	0.00157	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	0.000942	0.00153	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—FOXO1—muscle cancer	0.000936	0.00152	CbGpPWpGaD
Sucralfate—FGA—Disease—ENO2—muscle cancer	0.000928	0.00151	CbGpPWpGaD
Sucralfate—EGF—B Cell Activation—MDM2—muscle cancer	0.000927	0.00151	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—MYOD1—muscle cancer	0.000926	0.00151	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—KIT—muscle cancer	0.000924	0.0015	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—KIT—muscle cancer	0.000909	0.00148	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	0.000908	0.00148	CbGpPWpGaD
Sucralfate—EGF—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	0.000887	0.00144	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—FOXO4—muscle cancer	0.000878	0.00143	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—KIT—muscle cancer	0.000868	0.00141	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—KIT—muscle cancer	0.000866	0.00141	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—KIT—muscle cancer	0.000864	0.00141	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—KIT—muscle cancer	0.00086	0.0014	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—KIT—muscle cancer	0.000855	0.00139	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—MED12—muscle cancer	0.000847	0.00138	CbGpPWpGaD
Sucralfate—FGA—Disease—HMGA1—muscle cancer	0.000844	0.00137	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—FOXO4—muscle cancer	0.000843	0.00137	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—KIT—muscle cancer	0.000843	0.00137	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—KIT—muscle cancer	0.000805	0.00131	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—KIT—muscle cancer	0.000805	0.00131	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—KIT—muscle cancer	0.000805	0.00131	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—KIT—muscle cancer	0.000798	0.0013	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—KIT—muscle cancer	0.000791	0.00129	CbGpPWpGaD
Sucralfate—ALB—Platelet degranulation—IGF2—muscle cancer	0.00079	0.00129	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—KIT—muscle cancer	0.000787	0.00128	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CD34—muscle cancer	0.000785	0.00128	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—IGF2—muscle cancer	0.000783	0.00127	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—MDM2—muscle cancer	0.00076	0.00124	CbGpPWpGaD
Sucralfate—FGA—Disease—FOXO4—muscle cancer	0.000757	0.00123	CbGpPWpGaD
Sucralfate—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—muscle cancer	0.000753	0.00123	CbGpPWpGaD
Sucralfate—EGF—Immune System—CD34—muscle cancer	0.000752	0.00122	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—KIT—muscle cancer	0.000745	0.00121	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—MDM2—muscle cancer	0.000727	0.00118	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—FOXO1—muscle cancer	0.00072	0.00117	CbGpPWpGaD
Sucralfate—EGF—Focal Adhesion—VEGFA—muscle cancer	0.000719	0.00117	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—MDM2—muscle cancer	0.000716	0.00117	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	0.000716	0.00116	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—KIT—muscle cancer	0.000713	0.00116	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—MDM2—muscle cancer	0.000684	0.00111	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—MDM2—muscle cancer	0.000682	0.00111	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—MDM2—muscle cancer	0.00068	0.00111	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—MDM2—muscle cancer	0.000677	0.0011	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—MDM2—muscle cancer	0.000674	0.0011	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—MDM2—muscle cancer	0.000664	0.00108	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—FOXO1—muscle cancer	0.000648	0.00106	CbGpPWpGaD
Sucralfate—EGF—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.000637	0.00104	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—MDM2—muscle cancer	0.000634	0.00103	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—MDM2—muscle cancer	0.000634	0.00103	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—MDM2—muscle cancer	0.000634	0.00103	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—PTCH1—muscle cancer	0.000629	0.00102	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—MDM2—muscle cancer	0.000628	0.00102	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—FOXO1—muscle cancer	0.000623	0.00101	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—MDM2—muscle cancer	0.000623	0.00101	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—MDM2—muscle cancer	0.00062	0.00101	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—KIDINS220—muscle cancer	0.000618	0.00101	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—PTCH1—muscle cancer	0.000616	0.001	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—PTCH1—muscle cancer	0.000616	0.001	CbGpPWpGaD
Sucralfate—EGF—MAPK Signaling Pathway—TP53—muscle cancer	0.000599	0.000975	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	0.000596	0.000971	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—MDM2—muscle cancer	0.000587	0.000955	CbGpPWpGaD
Sucralfate—EGF—Disease—ENO2—muscle cancer	0.000579	0.000943	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	0.000575	0.000936	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	0.000561	0.000914	CbGpPWpGaD
Sucralfate—FGA—Disease—FOXO1—muscle cancer	0.000559	0.00091	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—FOXO4—muscle cancer	0.000556	0.000905	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—KIT—muscle cancer	0.000548	0.000892	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—FOXO4—muscle cancer	0.000541	0.00088	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	0.000541	0.00088	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—VEGFA—muscle cancer	0.000537	0.000874	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—FOXO4—muscle cancer	0.000534	0.000869	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CNR1—muscle cancer	0.000531	0.000864	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—FOXO4—muscle cancer	0.00053	0.000862	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—FOXO4—muscle cancer	0.00053	0.000862	CbGpPWpGaD
Sucralfate—EGF—Disease—HMGA1—muscle cancer	0.000526	0.000857	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—VEGFA—muscle cancer	0.000526	0.000856	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—VEGFA—muscle cancer	0.000526	0.000856	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CNR1—muscle cancer	0.00052	0.000847	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CNR1—muscle cancer	0.00052	0.000847	CbGpPWpGaD
Sucralfate—EGF—Immune System—FOXO4—muscle cancer	0.000511	0.000833	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—KIT—muscle cancer	0.000494	0.000804	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CD34—muscle cancer	0.000476	0.000775	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—KIT—muscle cancer	0.000474	0.000772	CbGpPWpGaD
Sucralfate—EGF—Disease—FOXO4—muscle cancer	0.000472	0.000769	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—FOXO1—muscle cancer	0.000465	0.000756	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	0.000453	0.000737	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—IGF2—muscle cancer	0.000434	0.000706	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—MDM2—muscle cancer	0.000432	0.000703	CbGpPWpGaD
Sucralfate—FGA—Disease—KIT—muscle cancer	0.000426	0.000693	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—IGF2—muscle cancer	0.000425	0.000692	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—IGF2—muscle cancer	0.000425	0.000692	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—FOXO1—muscle cancer	0.00041	0.000668	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—TP53—muscle cancer	0.000406	0.00066	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—FOXO1—muscle cancer	0.000399	0.00065	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—TP53—muscle cancer	0.000397	0.000647	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—TP53—muscle cancer	0.000397	0.000647	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—FOXO1—muscle cancer	0.000394	0.000642	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—FOXO1—muscle cancer	0.000391	0.000637	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—FOXO1—muscle cancer	0.000391	0.000637	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—PTGS2—muscle cancer	0.00039	0.000634	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—MDM2—muscle cancer	0.000389	0.000633	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PTCH1—muscle cancer	0.000385	0.000626	CbGpPWpGaD
Sucralfate—EGF—Immune System—FOXO1—muscle cancer	0.000378	0.000615	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—MDM2—muscle cancer	0.000374	0.000608	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—ANGPT2—muscle cancer	0.000371	0.000605	CbGpPWpGaD
Sucralfate—FGF2—Disease—ENO2—muscle cancer	0.000367	0.000597	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—IGF2—muscle cancer	0.00035	0.00057	CbGpPWpGaD
Sucralfate—EGF—Disease—FOXO1—muscle cancer	0.000349	0.000568	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	0.000342	0.000557	CbGpPWpGaD
Sucralfate—FGA—Disease—MDM2—muscle cancer	0.000335	0.000546	CbGpPWpGaD
Sucralfate—FGF2—Disease—HMGA1—muscle cancer	0.000333	0.000542	CbGpPWpGaD
Sucralfate—ALB—Platelet degranulation—VEGFA—muscle cancer	0.000331	0.000539	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—FOXO4—muscle cancer	0.000331	0.000538	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—VEGFA—muscle cancer	0.000328	0.000534	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CNR1—muscle cancer	0.000325	0.000528	CbGpPWpGaD
Sucralfate—FGF2—Immune System—FOXO4—muscle cancer	0.000324	0.000527	CbGpPWpGaD
Sucralfate—FGA—Disease—PTGS2—muscle cancer	0.000323	0.000526	CbGpPWpGaD
Sucralfate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—muscle cancer	0.000316	0.000514	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—KIT—muscle cancer	0.000313	0.000509	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—KIT—muscle cancer	0.000304	0.000495	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—KIT—muscle cancer	0.0003	0.000489	CbGpPWpGaD
Sucralfate—FGF2—Disease—FOXO4—muscle cancer	0.000299	0.000486	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—KIT—muscle cancer	0.000298	0.000485	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—KIT—muscle cancer	0.000298	0.000485	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—TP53—muscle cancer	0.000292	0.000475	CbGpPWpGaD
Sucralfate—EGF—Immune System—KIT—muscle cancer	0.000288	0.000468	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.000276	0.000449	CbGpPWpGaD
Sucralfate—EGF—Disease—KIT—muscle cancer	0.000266	0.000433	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IGF2—muscle cancer	0.000265	0.000432	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—TP53—muscle cancer	0.000248	0.000404	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—MDM2—muscle cancer	0.000246	0.000401	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—FOXO1—muscle cancer	0.000244	0.000398	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PTCH1—muscle cancer	0.000243	0.000396	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—MDM2—muscle cancer	0.00024	0.00039	CbGpPWpGaD
Sucralfate—FGF2—Immune System—FOXO1—muscle cancer	0.000239	0.000389	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—MDM2—muscle cancer	0.000236	0.000385	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—MDM2—muscle cancer	0.000235	0.000382	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—MDM2—muscle cancer	0.000235	0.000382	CbGpPWpGaD
Sucralfate—EGF—Immune System—MDM2—muscle cancer	0.000227	0.000369	CbGpPWpGaD
Sucralfate—FGF2—Disease—FOXO1—muscle cancer	0.000221	0.000359	CbGpPWpGaD
Sucralfate—ALB—Metabolism—FH—muscle cancer	0.000217	0.000354	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—VEGFA—muscle cancer	0.000212	0.000345	CbGpPWpGaD
Sucralfate—EGF—Disease—MDM2—muscle cancer	0.000209	0.000341	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—FOXO4—muscle cancer	0.000209	0.000341	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CNR1—muscle cancer	0.000205	0.000334	CbGpPWpGaD
Sucralfate—EGF—Disease—PTGS2—muscle cancer	0.000202	0.000328	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—KIT—muscle cancer	0.000186	0.000303	CbGpPWpGaD
Sucralfate—FGF2—Immune System—KIT—muscle cancer	0.000182	0.000296	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—VEGFA—muscle cancer	0.000182	0.000296	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—IGF2—muscle cancer	0.000181	0.000294	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—VEGFA—muscle cancer	0.000178	0.00029	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—VEGFA—muscle cancer	0.000178	0.00029	CbGpPWpGaD
Sucralfate—FGF2—Disease—KIT—muscle cancer	0.000168	0.000274	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IGF2—muscle cancer	0.000168	0.000273	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—FOXO1—muscle cancer	0.000155	0.000252	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.000147	0.000239	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MDM2—muscle cancer	0.000147	0.000239	CbGpPWpGaD
Sucralfate—FGF2—Immune System—MDM2—muscle cancer	0.000143	0.000234	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TP53—muscle cancer	0.000138	0.000224	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TP53—muscle cancer	0.000135	0.000219	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TP53—muscle cancer	0.000135	0.000219	CbGpPWpGaD
Sucralfate—FGF2—Disease—MDM2—muscle cancer	0.000132	0.000216	CbGpPWpGaD
Sucralfate—FGF2—Disease—PTGS2—muscle cancer	0.000128	0.000208	CbGpPWpGaD
Sucralfate—ALB—Metabolism—MED12—muscle cancer	0.000123	0.0002	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—KIT—muscle cancer	0.000118	0.000192	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ENO2—muscle cancer	0.000112	0.000182	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—VEGFA—muscle cancer	0.000111	0.000181	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MDM2—muscle cancer	9.27e-05	0.000151	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	8.75e-05	0.000143	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TP53—muscle cancer	8.41e-05	0.000137	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—VEGFA—muscle cancer	7.57e-05	0.000123	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—VEGFA—muscle cancer	7.04e-05	0.000115	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TP53—muscle cancer	5.72e-05	9.32e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TP53—muscle cancer	5.32e-05	8.66e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PTGS2—muscle cancer	3.9e-05	6.35e-05	CbGpPWpGaD
